Have you heard about MPE’s European #YoungMyelomaPatients Group?

It is a platform tailored for patients under 55 to connect, share experiences and swap resources. Plus, we host quarterly webinars led by experts!

Want to learn more? Click here: mpeurope.org/european-young…

MPE´s research assistant Silene ten Seldam and Hans Scheurer presented at the fourth IMI_SISAQOL -IMI consensus meeting on the patient perspectives on PRO's and the patient community's future use of the IMI_SISAQOL -IMI recommendations.

📢Join us today for the webinar discussing the 'New EU HTA Regulation and Implications for Patients' presented by MPE and Acute Leukemia Advocates Network (ALAN)

Gain insights from Béla Dajka, Policy Officer at the European Commission.

Secure your spot now: mpeurope-org.zoom.us/webinar/regist…

#EUHTA #PatientAdvocacy

MPE, representing WECAN, is providing the patient perspective and voting on the latest, IMI_SISAQOL -IMI recommendation statements at the fourth consensus meeting in Hamburg, Germany.

Few hours left and still time to register !

#Alan #AcuteLeukemia #BeLeukemia #BeAware #webinar #doctor #qrcode #may #BélaDajka #EuropeanCommission #foodsafety #MPE #MyelomaPatientsEurope #healthtecnology #Patients #Patients Organisations

Join us today at the online event with Mira Armour of the launch of the Economist Impact report and discussion on the state of MM care in the region. Thank you Johnson&Johnson on sponsoring this report. International Myeloma Foundation Myeloma Patients Europe #equitable #myeloma

📢Join our webinar focusing on disease and treatment specifics for young myeloma patients.

🗓️Date: 29 May, 2024
🕓Time: 16:00 – 17:00 CET.

Prof. Dr. Michel Delforge will share insights during his 40-min presentation and a 20-min Q&A session.

mpeurope-org.zoom.us/webinar/regist…

The video and photo gallery of the #MPEMasterclass 2024 is on our website!

Click on the link and check out the video interviews and photos of all the sessions and panel discussions during the MPE Masterclass weekend in Madrid, Spain.

mpeurope.org/what-we-do/pro…

Sign up and participate in MPE activities!

Whether you want to advocate, share experiences, or learn more, our community has a place for you.

📝Together, we can make a difference.

Sign up now:mpeurope.org/get-involved-i…

📢 Join us for a webinar discussing the 'New EU HTA Regulations and Implications for Patients' presented by MPE and Acute Leukemia Advocates Network (ALAN) on May 22nd at 15:00 CEST.

Gain insights from Béla Dajka, Policy Officer at the European Commission.

Secure your spot now:mpeurope-org.zoom.us/webinar/regist…

Through the Navigator, #myeloma and #ALamyloidosis patients can search for clinical trials in Europe. You can find trials aligned with your requirements, whether it is a certain hospital or a specific disease stage.

Discover the MPE Navigator: navigator.mpeurope.org/en

📢 Do not miss our webinar on 'New EU HTA Regulations and Implications for Patients' by MPE and
Acute Leukemia Advocates Network (ALAN) on 22 May at 15:00 CEST.

Learn from Béla Dajka, Policy Officer at the European Commission.
Register now here: mpeurope-org.zoom.us/webinar/regist…

📅 From 4 to 5 May, Claudia Louati, Head of Policy at EPF and Valentina Strammiello, Director of Programmes at EPF attended the MPE Masterclass 2024, organised by Myeloma Patients Europe.

During their interventions, they discussed #HTA and access to healthcare in the EU!

Delighted to be part of this important session Myeloma Patients Europe masterclass in Madrid!

Access to supportive care, including #rehabilitation , psychological support, nutrition and specialist nursing care, increasingly crucial to living well with myeloma

#RightToRehab

As the #MPEMasterclass comes to an end, MPE´s Head of Medical Education and Scientific Engagement, Solène Clavreul, is speaking about the MPE Clinical Trial Navigator.

You can learn more about the #MPENavigator here: navigator.mpeurope.org/en

Diane Loening-Martens wrapping up our last session of the #MPEMasterclass : “Access to supportive care in cancer is our right. And we need to demand that and fight for it.”
#myeloma #PatientAdvocacy

The #MPEMasterclass panel discussion on supportive care for #myeloma and #ALamyloidosis patients is going on right now.

Experts Surabhi Chaturvedi, Dr. Orla McCourt, Dr. Mirjana Rajer and Christine Skeet are sharing insights and best practices.

#SupportiveCare